Akoya receives unsolicited $1.40/share cash offer, board evaluating as Superior Proposal

Akoya Biosciences, Inc.

Unsolicited all-cash proposal values each Akoya share at $1.40, received May 20, 2025.
Board, with advisors, is reviewing the proposal and will engage with the third party.
Board determines proposal could reasonably lead to a Superior Proposal under the existing Quanterix merger agreement.
Board continues to recommend the pending merger with Quanterix despite the unsolicited offer.
No assurance the unsolicited proposal will result in a Superior Proposal or definitive agreement.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.